Lataa...
Safety of intravenous immunoglobulin treatment.
In a prospective clinical and biochemical study of 16 patients treated with high doses of an immunoglobulin product that had been modified for intravenous use by mild pepsin treatment at pH 4 no evidence of hepatitis could be found. This contrasts with recent reports that intravenous immunoglobulin...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1985
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC499468/ https://ncbi.nlm.nih.gov/pubmed/3932489 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|